{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:22:47Z","timestamp":1792178567400,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"The national research foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2022R1F1A1069431"],"award-info":[{"award-number":["NRF-2022R1F1A1069431"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"The national research foundation of Korea","doi-asserted-by":"crossref","award":["MRC, 2017R1A5A2015541"],"award-info":[{"award-number":["MRC, 2017R1A5A2015541"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021084","name":"Ulsan University Hospital","doi-asserted-by":"publisher","award":["UUH-2020-07"],"award-info":[{"award-number":["UUH-2020-07"]}],"id":[{"id":"10.13039\/501100021084","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Ministry of Food and Drug Safety of Korea","award":["20182MFDS425"],"award-info":[{"award-number":["20182MFDS425"]}]},{"name":"The Ministry of Food and Drug Safety of Korea","award":["22214MFDS252"],"award-info":[{"award-number":["22214MFDS252"]}]},{"name":"The Ministry of Food and Drug Safety of Korea","award":["23212MFDS217"],"award-info":[{"award-number":["23212MFDS217"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76258-4","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T04:43:52Z","timestamp":1730090632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Targeting the VEGFR2 signaling pathway for angiogenesis and fibrosis regulation in neovascular age-related macular degeneration"],"prefix":"10.1038","volume":"14","author":[{"given":"Eunhye","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haechan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeonji","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghwa","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjeong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Moon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Kee","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaesuk","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"key":"76258_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"NG Lambert","year":"2016","unstructured":"Lambert, N. G. et al. Risk factors and biomarkers of age-related macular degeneration. Prog. Retin. Eye Res. 54, 64\u2013102. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.003 (2016).","journal-title":"Prog. Retin. Eye Res."},{"key":"76258_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1350-9462(02)00043-5","volume":"22","author":"AN Witmer","year":"2003","unstructured":"Witmer, A. N., Vrensen, G. F., Van Noorden, C. J. & Schlingemann, R. O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22, 1\u201329. https:\/\/doi.org\/10.1016\/s1350-9462(02)00043-5 (2003).","journal-title":"Prog. Retin. Eye Res."},{"issue":"633","key":"76258_CR3","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1016\/j.ophtha.2005.10.052","volume":"113","author":"JS Heier","year":"2006","unstructured":"Heier, J. S. et al. Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I\/II multicenter, controlled, multidose study. Ophthalmology 113(633), e631-634. https:\/\/doi.org\/10.1016\/j.ophtha.2005.10.052 (2006).","journal-title":"Ophthalmology"},{"key":"76258_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419\u20131431. https:\/\/doi.org\/10.1056\/NEJMoa054481 (2006).","journal-title":"N. Engl. J. Med."},{"key":"76258_CR5","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier, J. S. et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119, 2537\u20132548. https:\/\/doi.org\/10.1016\/j.ophtha.2012.09.006 (2012).","journal-title":"Ophthalmology"},{"key":"76258_CR6","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ophtha.2014.05.009","volume":"121","author":"AC Ho","year":"2014","unstructured":"Ho, A. C. et al. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 121, 2181\u20132192. https:\/\/doi.org\/10.1016\/j.ophtha.2014.05.009 (2014).","journal-title":"Ophthalmology"},{"key":"76258_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","volume":"121","author":"E Daniel","year":"2014","unstructured":"Daniel, E. et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121, 656\u2013666. https:\/\/doi.org\/10.1016\/j.ophtha.2013.10.019 (2014).","journal-title":"Ophthalmology"},{"key":"76258_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch, S. & Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2, a006502. https:\/\/doi.org\/10.1101\/cshperspect.a006502 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"76258_CR9","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1167\/iovs.17-21416","volume":"58","author":"KL Kim","year":"2017","unstructured":"Kim, K. L. & Suh, W. Apatinib, an inhibitor of vascular endothelial growth factor receptor 2, suppresses pathologic ocular neovascularization in mice. Investig. Ophthalmol. Vis. Sci. 58, 3592\u20133599. https:\/\/doi.org\/10.1167\/iovs.17-21416 (2017).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"76258_CR10","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2, 1097\u20131105. https:\/\/doi.org\/10.1177\/1947601911423031 (2011).","journal-title":"Genes Cancer"},{"key":"76258_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/icb.2016.109","volume":"95","author":"J Luo","year":"2017","unstructured":"Luo, J. et al. Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis. Immunol. Cell Biol. 95, 399\u2013407. https:\/\/doi.org\/10.1038\/icb.2016.109 (2017).","journal-title":"Immunol. Cell Biol."},{"key":"76258_CR12","doi-asserted-by":"publisher","first-page":"10945","DOI":"10.1002\/jcb.28489","volume":"120","author":"J Zhang","year":"2019","unstructured":"Zhang, J. & Chu, M. Differential roles of VEGF: Relevance to tissue fibrosis. J. Cell. Biochem. 120, 10945\u201310951. https:\/\/doi.org\/10.1002\/jcb.28489 (2019).","journal-title":"J. Cell. Biochem."},{"key":"76258_CR13","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1158\/0008-5472.Can-04-4281","volume":"65","author":"JV Alvarez","year":"2005","unstructured":"Alvarez, J. V. et al. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res 65, 5054\u20135062. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-4281 (2005).","journal-title":"Cancer Res"},{"key":"76258_CR14","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3892\/mmr.2020.11344","volume":"22","author":"S Hwang","year":"2020","unstructured":"Hwang, S. et al. Phosphorylation of STAT3 and ERBB2 mediates hypoxia-induced VEGF release in ARPE-19 cells. Mol. Med. Rep. 22, 2733\u20132740. https:\/\/doi.org\/10.3892\/mmr.2020.11344 (2020).","journal-title":"Mol. Med. Rep."},{"key":"76258_CR15","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41374-018-0127-3","volume":"98","author":"Z Wang","year":"2018","unstructured":"Wang, Z., Li, J., Xiao, W., Long, J. & Zhang, H. The STAT3 inhibitor S3I\u2013201 suppresses fibrogenesis and angiogenesis in liver fibrosis. Lab. Investig. 98, 1600\u20131613. https:\/\/doi.org\/10.1038\/s41374-018-0127-3 (2018).","journal-title":"Lab. Investig."},{"key":"76258_CR16","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/j.1349-7006.2011.01939.x","volume":"102","author":"S Tian","year":"2011","unstructured":"Tian, S. et al. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo. Cancer Sci. 102, 1374\u20131380. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01939.x (2011).","journal-title":"Cancer Sci."},{"key":"76258_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.canlet.2016.01.014","volume":"372","author":"G Roviello","year":"2016","unstructured":"Roviello, G. et al. Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. Cancer Lett. 372, 187\u2013191. https:\/\/doi.org\/10.1016\/j.canlet.2016.01.014 (2016).","journal-title":"Cancer Lett."},{"key":"76258_CR18","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41467-017-01236-6","volume":"8","author":"D Chakraborty","year":"2017","unstructured":"Chakraborty, D. et al. Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nat. Commun. 8, 1130. https:\/\/doi.org\/10.1038\/s41467-017-01236-6 (2017).","journal-title":"Nat. Commun."},{"key":"76258_CR19","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/ijms19082299","volume":"19","author":"MM Kasembeli","year":"2018","unstructured":"Kasembeli, M. M., Bharadwaj, U., Robinson, P. & Tweardy, D. J. Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment. Int. J. Mol. Sci. 19, 2299. https:\/\/doi.org\/10.3390\/ijms19082299 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"76258_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-021-02069-4","volume":"40","author":"C Xie","year":"2021","unstructured":"Xie, C. et al. Apatinib triggers autophagic and apoptotic cell death via VEGFR2\/STAT3\/PD-L1 and ROS\/Nrf2\/p62 signaling in lung cancer. J. Exp. Clin. Cancer Res. 40, 266. https:\/\/doi.org\/10.1186\/s13046-021-02069-4 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"76258_CR21","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","volume":"122","author":"AS Willoughby","year":"2015","unstructured":"Willoughby, A. S. et al. Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials. Ophthalmology 122, 1846-1853.e1845. https:\/\/doi.org\/10.1016\/j.ophtha.2015.05.042 (2015).","journal-title":"Ophthalmology"},{"key":"76258_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.intimp.2008.10.002","volume":"9","author":"XM Ou","year":"2009","unstructured":"Ou, X. M. et al. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Int. Immunopharmacol. 9, 70\u201379. https:\/\/doi.org\/10.1016\/j.intimp.2008.10.002 (2009).","journal-title":"Int. Immunopharmacol."},{"key":"76258_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1042\/cs20140823","volume":"129","author":"Z Yan","year":"2015","unstructured":"Yan, Z. et al. CD147 promotes liver fibrosis progression via VEGF-A\/VEGFR2 signalling-mediated cross-talk between hepatocytes and sinusoidal endothelial cells. Clin. Sci. (Lond.) 129, 699\u2013710. https:\/\/doi.org\/10.1042\/cs20140823 (2015).","journal-title":"Clin. Sci. (Lond.)"},{"key":"76258_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-020-00378-9","volume":"6","author":"X Su","year":"2020","unstructured":"Su, X. et al. FN-EDA mediates angiogenesis of hepatic fibrosis via integrin-VEGFR2 in a CD63 synergetic manner. Cell Death Discov. 6, 140. https:\/\/doi.org\/10.1038\/s41420-020-00378-9 (2020).","journal-title":"Cell Death Discov."},{"key":"76258_CR25","first-page":"1891","volume":"40","author":"H Oh","year":"1999","unstructured":"Oh, H. et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Investig. Ophthalmol. Vis. Sci. 40, 1891\u20131898 (1999).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"76258_CR26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1440-1827.2011.02695.x","volume":"61","author":"X Cao","year":"2011","unstructured":"Cao, X. et al. Macrophage polarization in the maculae of age-related macular degeneration: A pilot study. Pathol. Int. 61, 528\u2013535. https:\/\/doi.org\/10.1111\/j.1440-1827.2011.02695.x (2011).","journal-title":"Pathol. Int."},{"key":"76258_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/039463201302600206","volume":"26","author":"YB Shaik-Dasthagirisaheb","year":"2013","unstructured":"Shaik-Dasthagirisaheb, Y. B. et al. Vascular endothelial growth factor (VEGF), mast cells and inflammation. Int. J Immunopathol. Pharmacol. 26, 327\u2013335. https:\/\/doi.org\/10.1177\/039463201302600206 (2013).","journal-title":"Int. J Immunopathol. Pharmacol."},{"key":"76258_CR28","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1091\/mbc.12.9.2730","volume":"12","author":"B Hinz","year":"2001","unstructured":"Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G. & Chaponnier, C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 12, 2730\u20132741. https:\/\/doi.org\/10.1091\/mbc.12.9.2730 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"76258_CR29","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1091\/mbc.e02-11-0729","volume":"14","author":"B Hinz","year":"2003","unstructured":"Hinz, B., Dugina, V., Ballestrem, C., Wehrle-Haller, B. & Chaponnier, C. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol. Biol. Cell 14, 2508\u20132519. https:\/\/doi.org\/10.1091\/mbc.e02-11-0729 (2003).","journal-title":"Mol. Biol. Cell"},{"key":"76258_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exer.2015.03.009","volume":"142","author":"K Ishikawa","year":"2016","unstructured":"Ishikawa, K., Kannan, R. & Hinton, D. R. Molecular mechanisms of subretinal fibrosis in age-related macular degeneration. Exp. Eye Res. 142, 19\u201325. https:\/\/doi.org\/10.1016\/j.exer.2015.03.009 (2016).","journal-title":"Exp. Eye Res."},{"key":"76258_CR31","doi-asserted-by":"publisher","first-page":"19641","DOI":"10.1074\/jbc.M114.630111","volume":"290","author":"XH Liao","year":"2015","unstructured":"Liao, X. H. et al. STAT3 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J. Biol. Chem. 290, 19641\u201319652. https:\/\/doi.org\/10.1074\/jbc.M114.630111 (2015).","journal-title":"J. Biol. Chem."},{"key":"76258_CR32","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41598-017-02907-6","volume":"7","author":"XH Liao","year":"2017","unstructured":"Liao, X. H. et al. VEGF-A stimulates STAT3 activity via nitrosylation of myocardin to regulate the expression of vascular smooth muscle cell differentiation markers. Sci. Rep. 7, 2660. https:\/\/doi.org\/10.1038\/s41598-017-02907-6 (2017).","journal-title":"Sci. Rep."},{"key":"76258_CR33","doi-asserted-by":"publisher","first-page":"14316","DOI":"10.1038\/s41598-022-18531-y","volume":"12","author":"E Yu","year":"2022","unstructured":"Yu, E. et al. Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models. Sci. Rep. 12, 14316. https:\/\/doi.org\/10.1038\/s41598-022-18531-y (2022).","journal-title":"Sci. Rep."},{"key":"76258_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput, W., Mes, J. J. & Wichers, H. J. THP-1 cell line: An in vitro cell model for immune modulation approach. Int. Immunopharmacol. 23, 37\u201345. https:\/\/doi.org\/10.1016\/j.intimp.2014.08.002 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"76258_CR35","doi-asserted-by":"publisher","DOI":"10.3791\/59683","author":"H L\u00e9ger","year":"2019","unstructured":"L\u00e9ger, H., Santana, E., Beltran, W. A. & Luca, F. C. Preparation of mouse retinal cryo-sections for immunohistochemistry. J. Vis. Exp.https:\/\/doi.org\/10.3791\/59683 (2019).","journal-title":"J. Vis. Exp."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76258-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76258-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:01:39Z","timestamp":1730091699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76258-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76258"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76258-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25682"}}